We have also discovered that PI polyamides which could specifically recognize and bind to RUNX binding sites strongly inhibit the proliferation of various types of cancers including gastric cancer, suggesting that RUNX1 inhibition could be a legitimate therapeutic choice in the management of gastric cancer22. This evidence concerns the gene RUNX1 and gastric cancer.